Skin Manifestations Clinical Trial
Official title:
Effect of Oral Collagen Tripeptide on Skin Moisture and Wrinkles in Adult Women
Verified date | August 2018 |
Source | Pusan National University Yangsan Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Comparison of a randomized, double-blind, and control-group study for the effect of oral ingestion of collagen tripeptides derived from fish on dermal moistures and wrinkles body fat reduction in participants
Status | Completed |
Enrollment | 84 |
Est. completion date | July 30, 2018 |
Est. primary completion date | July 15, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 40 Years to 60 Years |
Eligibility |
Inclusion Criteria: - > = 4 of Tewameter Exclusion Criteria: - Within the last 6 months, took skin surgery including cosmetic purpose - Diabetic patients with poor glycemic control with a fasting blood glucose of 160 mg/dl or more - Creatinine levels: more than twice the normal upper limit - AST (GOT) or ALT (GPT) levels: more than twice the normal upper limit - Uncontrolled hypertension - sun allergy or sensitive skin - functional cosmetics that affect dermal moistures and wrinkles within the last 3 months. - If you have participated or are planning to participate in another clinical trial within the past month - Alcohol abuser - If they are pregnant or lactating or have a pregnancy plan during the clinical trial Those with allergic reactions to the constituent food - Any person deemed inappropriate by the researcher for other reasons |
Country | Name | City | State |
---|---|---|---|
Korea, Republic of | Integrated Research Institute for Natural Ingredients and Functional Foods | Yangsan |
Lead Sponsor | Collaborator |
---|---|
Pusan National University Yangsan Hospital |
Korea, Republic of,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | changes in Transepidermal Waterloss by Tewameter | comparison between baseline, after 6 weeks, and after 12 weeks | baseline, after 6 weeks, and after 12 weeks | |
Secondary | changes in skin wrinkling indices by Visiometer | comparison between baseline, after 6 weeks, and after 12 weeks | baseline, after 6 weeks, and after 12 weeks | |
Secondary | skin elasticity by Cutometer | comparison between baseline, after 6 weeks, and after 12 weeks | baseline, after 6 weeks, and after 12 weeks | |
Secondary | changes in hydration level of the skin surface by Corneometer | comparison between baseline, after 6 weeks, and after 12 weeks | baseline, after 6 weeks, and after 12 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05597254 -
Facial Skin Clinical and Microbial Profiling From Oral Probiotic Supplementation
|
N/A | |
Active, not recruiting |
NCT06140628 -
A 28-day Clinical Study on Facial Skin Rejuvenation
|
N/A | |
Completed |
NCT04154436 -
Effectiveness, Safety, and Cost Efficacy of Water (H2O) as a Substitute for Sodium Bicarbonate (NaHCO3) Plus Solution in Neutralization of Chemical Peeling Using 35% Glycolic Acid Solution
|
N/A | |
Withdrawn |
NCT02787356 -
Standard TDS Irritation Study: Trained Skin Grader vs. Digital Imaging
|
N/A | |
Completed |
NCT04449159 -
Efficacy of Vinh Wellness Collagen on Skin Health
|
N/A | |
Enrolling by invitation |
NCT06188338 -
A 56-day Clinical Study on Facial Skin Rejuvenation
|
N/A | |
Completed |
NCT01139047 -
Split-face Tolerability Comparison Between MetroGel® 1% vs Finacea® 15% in Subjects With Healthy Skin
|
Phase 4 | |
Completed |
NCT01139008 -
Split-Face Tolerability Comparison Between MetroGel® 1% Versus Finacea® 15% in Subjects With Healthy Skin
|
Phase 4 | |
Completed |
NCT05094687 -
Cutaneous Manifestations of Coronavirus Disease 2019(COVID-19).
|
||
Recruiting |
NCT05235997 -
Placebo Controlled Efficacy Evaluation of the Hydrolyzed Collagen Peptide In Adult Females
|
N/A | |
Completed |
NCT01046565 -
Tolerability Comparison Between Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin
|
Phase 1 | |
Completed |
NCT01046396 -
Tolerability Comparison of Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin
|
Phase 1 | |
Completed |
NCT04701463 -
A Specialized Amino Acid Mixture on Body Composition and Skin State in Overweight and Obese Class I Postmenopausal Women
|
N/A | |
Completed |
NCT02422836 -
Tolerability and Efficacy of Anti-Aging Treatment Regimen in Subjects With Photodamage
|
N/A | |
Completed |
NCT04002856 -
Aesthetic Performance of "Profhilo®" Injective Intradermal Treatment for the Neck
|
N/A | |
Completed |
NCT03873896 -
The Skin Wrinkle Test: a Simple Clinical Test of Regional Block Success
|
N/A | |
Active, not recruiting |
NCT06152718 -
New Regenerative Approach for Dermal Renovation (Karisma)
|
||
Recruiting |
NCT04344119 -
Assessment of Chilbains Occuring During Covid-19 Infection
|
||
Recruiting |
NCT06291415 -
The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP)
|
Phase 1 | |
Completed |
NCT05872178 -
Omegia Softgel Clinical Research Program
|
N/A |